Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: Impact of budesonide treatment and withdrawal

This publication has 26 references indexed in Scilit:

• Conditions in blood sampling procedures that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls
  Annals of Allergy, Asthma & Immunology, 1999
• Blood Sample Processing Effect on Eosinophil Cationic Protein Concentration
  Annals of Allergy, Asthma & Immunology, 1997
• The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma
  Allergy, 1996
• Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population
  Allergy, 1994
• Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy
  Clinical and Experimental Allergy, 1993
• Eosinophil cationic protein (ECP), eosinophil chemotactic activity (ECA), neutrophil chemotactic activity (NCA) and tryptase in serum before and during bronchial challenge in cat‐allergic children with asthma
  Pediatric Allergy and Immunology, 1992
• A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid
  Clinical and Experimental Allergy, 1992
• Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained
  Journal of Allergy and Clinical Immunology, 1991
• Secretion of granule proteins from eosinophils and neutrophils is increased in asthma
  Journal of Allergy and Clinical Immunology, 1991
• Standardization of bronchial inhalation challenge procedures
  Journal of Allergy and Clinical Immunology, 1975